Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein

J Gen Virol. 2020 Jun;101(6):573-586. doi: 10.1099/jgv.0.001414. Epub 2020 Apr 24.

Abstract

Bone marrow stromal cell antigen-2 (BST-2), also known as tetherin, is an interferon-inducible membrane-associated protein. It effectively targets enveloped viruses at the release step of progeny viruses from host cells, thereby restricting the further spread of viral infection. Junin virus (JUNV) is a member of Arenaviridae, which causes Argentine haemorrhagic fever that is associated with a high rate of mortality. In this study, we examined the effect of human BST-2 on the replication and propagation of JUNV. The production of JUNV Z-mediated virus-like particles (VLPs) was significantly inhibited by over-expression of BST-2. Electron microscopy analysis revealed that BST-2 functions by forming a physical link that directly retains VLPs on the cell surface. Infection using JUNV showed that infectious JUNV production was moderately inhibited by endogenous or exogenous BST-2. We also observed that JUNV infection triggers an intense interferon response, causing an upregulation of BST-2, in infected cells. However, the expression of cell surface BST-2 was reduced upon infection. Furthermore, the expression of JUNV nucleoprotein (NP) partially recovered VLP production from BST-2 restriction, suggesting that the NP functions as an antagonist against antiviral effect of BST-2. We further showed that JUNV NP also rescued the production of Ebola virus VP40-mediated VLP from BST-2 restriction as a broad spectrum BST-2 antagonist. To our knowledge, this is the first report showing that an arenavirus protein counteracts the antiviral function of BST-2.

Keywords: Arenaviridae; Junin virus; Tetherin; human BST-2; innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Antigens, CD / metabolism*
  • Antiviral Agents / pharmacology
  • Cell Line
  • Cell Line, Tumor
  • GPI-Linked Proteins / metabolism
  • HEK293 Cells
  • HeLa Cells
  • Host-Pathogen Interactions / drug effects
  • Host-Pathogen Interactions / physiology*
  • Humans
  • Interferons / pharmacology
  • Junin virus / drug effects
  • Junin virus / physiology*
  • Nucleoproteins / metabolism*
  • Viral Core Proteins / metabolism*
  • Virus Release / drug effects
  • Virus Release / physiology*
  • Virus Replication / drug effects
  • Virus Replication / genetics

Substances

  • Antigens, CD
  • Antiviral Agents
  • BST2 protein, human
  • GPI-Linked Proteins
  • Nucleoproteins
  • Viral Core Proteins
  • nucleoprotein VP40, Ebola virus
  • Interferons